Quantification of Cardiotonic Steroids Potentially Regulated by Paraoxonase 3 in a Rat Model of Chronic Kidney Disease Using UHPLC-Orbitrap-MS

Quantification of Cardiotonic Steroids Potentially Regulated by Paraoxonase 3 in a Rat Model of Chronic Kidney Disease Using UHPLC-Orbitrap-MS

Endogenous cardiotonic steroids (CTSs), such as telocinobufagin (TCB) and marinobufagin (MBG) contain a lactone moiety critical to their binding and signaling through the Na<sup>+</sup>/K<sup>+</sup>-ATPase. Their concentrations elevate in response to sodium intake and under...

Full description

Bibliographic Details
Main Authors:	Sabitri Lamichhane, Chrysan J. Mohammed, Steven T. Haller, David J. Kennedy, Dragan Isailovic
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	International Journal of Molecular Sciences
Subjects:	endogenous cardiotonic steroids telocinobufagin marinobufagin paraoxonase urine SPE
Online Access:	https://www.mdpi.com/1422-0067/23/21/13565

Similar Items

Cardiotonic Steroids as Modulators of Neuroinflammation
by: Ana Maria Marques Orellana, et al.
Published: (2016-02-01)

Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids
by: Artem M. Tverskoi, et al.
Published: (2021-12-01)

Na,K-ATPase as a target for endogenous cardiotonic steroids: What's the evidence?
by: Sergei N. Orlov, et al.
Published: (2021-05-01)

Research Progress in Pharmacological Activities and Applications of Cardiotonic Steroids
by: Junwei Ren, et al.
Published: (2022-06-01)

Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads
by: Hesham R. El-Seedi, et al.
Published: (2022-10-01)

Broad Spectrum Antiviral Properties of Cardiotonic Steroids Used as Potential Therapeutics for Emerging Coronavirus Infections
by: Young-Hee Jin, et al.
Published: (2021-11-01)

Epithelial and Endothelial Adhesion of Immune Cells Is Enhanced by Cardiotonic Steroid Signaling Through Na+/K+‐ATPase‐α‐1
by: Fatimah K. Khalaf, et al.
Published: (2020-02-01)

A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease
by: Chrysan J. Mohammed, et al.
Published: (2022-03-01)

The cardiotonic properties of human apolipoprotein A-I
by: A. R. Kolpakov, et al.
Published: (2015-12-01)

The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study
by: Michél Strauss-Kruger, et al.
Published: (2020-10-01)

Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1<sup>s/s</sup>α2<sup>s/s</sup> Mouse Model of High Affinity for Cardiotonic Steroids
by: Pauline V. Marck, et al.
Published: (2021-03-01)

Na<sup>+</sup>,K<sup>+</sup>-ATPase and Cardiotonic Steroids in Models of Dopaminergic System Pathologies
by: Alisa A. Markina, et al.
Published: (2023-06-01)

Study on the development of liquid extract of cardiotonic action
by: O. S. Kukhtenko, et al.
Published: (2019-07-01)

Defence mitigation by predators of chemically defended prey integrated over the predation sequence and across biological levels with a focus on cardiotonic steroids
by: Shabnam Mohammadi, et al.
Published: (2022-09-01)

Usage of cardiotonic drugs at the intensive care units
by: Ruslan Baltaga, et al.
Published: (2017-04-01)

Cardiotonic properties of high density lipoproteins
by: L. E. Panin, et al.
Published: (2013-06-01)

C25 Phytochemical characterization and proposal of a cardiotonic mechanism of action of the methanolic extract of Caloncoba glauca (Flacourtiaceae) roots on isolated frog's heart
by: M. H. J Nko’o, et al.
Published: (2023-12-01)

Editorial: Natriuretic Hormones
by: Harvey Craig Gonick, et al.
Published: (2015-07-01)

A research update on the antitumor effects of active components of Chinese medicine ChanSu
by: Jinhao Jia, et al.
Published: (2022-09-01)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023-07-01)

Erysimum cheiri: The potential uterotonic medicinal herb
by: Ghazaleh Mosleh, et al.
Published: (2020-03-01)

Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
by: Fatimah K. Khalaf, et al.
Published: (2022-04-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
by: Nurhan Sarioglu, et al.
Published: (2015-02-01)

Processed lateral root of Aconitum carmichaelii Debx.: A review of cardiotonic effects and cardiotoxicity on molecular mechanisms
by: Jing Zhang, et al.
Published: (2022-10-01)

Endogenous Digitalis-like Factors as a Key Molecule in the Pathophysiology of Pregnancy-Induced Hypertension and a Potential Therapeutic Target in Preeclampsia
by: Maciej W. Socha, et al.
Published: (2023-08-01)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
by: Zahra Najafi Arab, et al.
Published: (2022-06-01)

Paraoxonases at the Heart of Neurological Disorders
by: Fatimah K. Khalaf, et al.
Published: (2023-04-01)

Molecular structure, spectral, computational, IEFPCM investigation, and topological study on the biologically potent; cardiotonic drug 2-chloroquinolin-3-amine with structural optimization
by: A. Saral, et al.
Published: (2023-06-01)

Cardioprotective Role for Paraoxonase-1 in Chronic Kidney Disease
by: Prabhatchandra Dube, et al.
Published: (2022-09-01)

Solid-phase extraction for determination of caffeine and its dimethylxanthine metabolites in rat urine using high performance liquid chromatography and its application
by: Keson Trakunram, et al.
Published: (2018-08-01)

Paraoxonase 1 Activity and Survival in Sepsis Patients
by: Volkan İnal, et al.
Published: (2015-06-01)

Paraoxonase 1 and atherosclerosis
by: Paul N. Durrington, et al.
Published: (2023-02-01)

The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases
by: Anna Wysocka, et al.
Published: (2021-02-01)

Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis
by: Aytac Atamer, et al.
Published: (2014-01-01)

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells
by: Gülben Sayılan Özgün, et al.
Published: (2017-12-01)

Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019-01-01)

Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients
by: Mehrdad Solati, et al.
Published: (2012-10-01)

Effect of Andrographolide on Paraoxonase 2 Expression in Male Wistar Rats
by: Reza Alipanah Moghadam, et al.
Published: (2018-05-01)

Modulação Dietética da Atividade da Paraoxonase: Revisão de Estudos em Humanos
by: Jaqueline Driemeyer Correia, et al.
Published: (2010-10-01)

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01)